POCone-UBiT-IR300 Pediatric Comparison Study
NCT01623154 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 99
Last updated 2015-02-23
Summary
The purpose of this study is to compare between the POCone® to the UBiT®-IR300 in measuring 13CO2/12CO2 ratio in breath samples when used together with the BreathTek® UBT (urea breath test) Kit and the pUHR-CA web-based software program in identifying H. pylori infection in pediatric subjects.
Conditions
- Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions
- OTHER
-
Pranactin citric solution
All patients were required to drink the pranactic citric solution to diagnose H.pylori.
Sponsors & Collaborators
-
Otsuka America Pharmaceutical
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 3 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2013-03-31
- Completion
- 2013-04-30
Countries
- United States
Study Locations
More Related Trials
-
Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection
NCT02934048 ·Status: UNKNOWN ·Phase: PHASE4
-
A Phase Ⅲ Clinical Trial With Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children
NCT02302170 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Vonoprazan-based Rescue Therapy for H. Pylori Eradication
NCT07130253 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study
NCT01335334 ·Status: UNKNOWN ·Phase: PHASE4
-
French Pediatric Helicobacter Pylori Observatory
NCT03541876 ·Status: UNKNOWN
-
Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori
NCT00712413 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
NCT05133193 ·Status: UNKNOWN ·Phase: NA
-
Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study
NCT07211880 ·Status: COMPLETED ·Phase: NA
-
Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection
NCT03521726 ·Status: COMPLETED ·Phase: PHASE4
-
Tailored Therapy for Helicobacter Pylori in Children
NCT02635191 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of a Synbiotic Addition on Eradication Therapy of Helicobacter Pylori Infection in Children
NCT03165253 ·Status: COMPLETED ·Phase: NA
-
Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection
NCT03524833 ·Status: COMPLETED ·Phase: PHASE4
-
H. Pylori Screen-and-treat Study in a Population of Young Adults
NCT06275204 ·Status: RECRUITING
-
Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.
NCT05432115 ·Status: UNKNOWN ·Phase: PHASE4
-
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
NCT07167511 ·Status: COMPLETED
-
The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection
NCT01032655 ·Status: COMPLETED ·Phase: PHASE4
-
Helicobacter Pylori Eradication Study
NCT03130452 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease
NCT07260006 ·Status: RECRUITING ·Phase: NA
-
The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial
NCT05586113 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Low-dose Vonoprazan for Helicobacter Pylori Eradication
NCT06037122 ·Status: UNKNOWN
-
Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori
NCT03556254 ·Status: UNKNOWN ·Phase: PHASE4
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection
NCT03565484 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
NCT02490839 ·Status: COMPLETED ·Phase: PHASE4
-
Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection
NCT03516669 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin
NCT02923856 ·Status: UNKNOWN ·Phase: NA